, /PRNewswire/ -- The National Institutes of Health (NIH) announced today that the Preeclampsia Foundation's program has been selected as a top 10 finalist in its . The national competition seeks to identify and support new and promising community-based strategies that leverage engagement to build trust and help increase participation by historically underserved populations (UP) in disease research and the adoption of medical care to detect, treat, and monitor diseases, conditions, and disorders. "We are honored to be named a finalist in this distinguished challenge," said , manager of the Take 10 for Preeclampsia Research program.
"The selection further bolsters the Preeclampsia Foundation's goal to amplify the voices of Black preeclampsia survivors in research to further our understanding of this pregnancy disorder." Preeclampsia is a pregnancy complication characterized by persistent high blood pressure and organ failure. The disorder, if left unmanaged, can lead to serious complications for both moms and babies.
Preeclampsia affects 5-8% of all pregnancies and Black women are 60% more likely to experience the condition. The Take 10 for Preeclampsia Research program, launched in , serves as a call-to-action designed by and for Black women to share their birth experiences with researchers through their enrollment in the foundation's Preeclampsia Registry. The registry, a patient-driven "living" repository, allows women to safely submit their experiences and opt-in to multip.
